Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447
Authors
Qingji Huo (ORCID: https://orcid.org/0000-0003-0438-6812)
Melissa L. Fishel (ORCID: https://orcid.org/0000-0002-9436-6382)
Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447
Qingji Huo, Melissa L. Fishel, Hiroki Yokota, Kexin Li et al.
Journal
Pharmaceutics
Topics
Peptidase Inhibition and Analysis
article
Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447
Qingji Huo, Melissa L. Fishel, Hiroki Yokota, Kexin Li, Xue Xiong, Bai‐Yan Li, Changpeng Cui
article en
Abstract
No abstract available for this paper.
Publication Tag
PharmaceuticsVol. 18(7)
Institutions
Indiana University Health (US), Harbin Medical University (CN), Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
Funders
National Natural Science Foundation of China, National Heart, Lung, and Blood Institute